Microbiology & Infectious Diseases

EACS 2025 study shows minimal HBV reactivation after stopping tenofovir in people with HIV, supporting safe use of tenofovir-sparing ART.

New EACS data show once-weekly islatravir and lenacapavir maintain HIV viral suppression for 96 weeks with no resistance or major side effects.

A new near point-of-care malaria diagnostic detects low-density infections in 45 minutes, supporting malaria elimination efforts across Africa.

Trace-positive sputum identifies a high-risk group for tuberculosis in Uganda. Chest x-ray abnormalities further highlight patients needing early treatment or monitoring.

Cefiderocol shows comparable effectiveness to standard care in treating carbapenem-resistant bloodstream infections, offering hope against superbugs.

A new global analysis reveals chikungunya virus is responsible for millions of infections annually across all continents, with chronic disease accounting for most of the health burden.

A broadly protective sarbecovirus vaccine could slow outbreaks, reduce deaths and give health systems critical time in future pandemics, new research suggests.

Researchers identify LRP8 as the essential receptor for tick-borne encephalitis virus in brain cells, offering new targets for antiviral therapy.